Hangzhou Shengshi Technology Co., Ltd. is dedicated to the research and development of biofluid mechanics, providing innovative products for precision diagnosis and treatment of circulatory disorders. Their offerings include AI-driven biomechanical diagnosis platforms, coronary artery flow reserve assessment software, coronary artery bypass planning software, and a cloud platform for computational fluid dynamics (CFD). The company focuses on developing non-invasive diagnostic solutions and advanced life support systems, leveraging cutting-edge artificial intelligence and cloud technologies to improve healthcare outcomes for cardiovascular diseases while aiming to enhance the quality of life for patients.

Sheng Shi Science and Technology (晟视科技)

Sheng Shi Science and Technology (晟视科技)